申请人:Fechter Cary Erwin
公开号:US20160367503A1
公开(公告)日:2016-12-22
Presented are combination medications a wakefulness agent, an established Alzheimer's medication, and antidepressants. The combination serves several purposes. It will simplify medication delivery for both the patient and caregiver. Such a convenience will improve medication compliance.
The combination selects neuro-stimulants which individually improve cognition while reducing known drug side-effects.
The specific components are Modafinil, bupropion, SSRI's and Donepezil.